share_log

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

Benzinga ·  Mar 20 15:14

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 252

Recommended

Write a comment